In the present study, we used bio specimens from a cohort of NB patients, a panel of stage 4 MYCN-na human cell lines coupled with appropriate in vitro, in vivo, and ex vivo NB models to investigate molecular alterations in MYCN-na NB cells that could lead to significant improvements in IMCT. Here, MYCN is linked to neuroblastoma.